Physiogenex
|
Year Established:
2003 |
|
|
Website:
physiogenex.com |
|
|
Headquarters:
ESCALQUENS, OCCITANIE, FR |
|
|
Company Type:
Small Business (1-10M TTM Revenue) |
Physiogenex is a preclinical contract research organization (CRO) specializing in metabolic and cardiovascular diseases. We provide, first level phenotyping and screening, efficacy and proof-of-concept studies in metabolic diseases, diabetes, insulin resistance, obesity, dyslipidemia, cardiometabolic, kidney diseases, and liver diseases (NAFLD/NASH/liver fibrosis), lung and kidney fibrosis.
We have a 20-year expertise in animal models of metabolic diseases and drug development. Our customer satisfaction rate is 97.5% in 2022.
| Site | Badges | |
|---|---|---|
| PHYSIOGENEX 280 RUE DE L'HERS ESCALQUENS, OCCITANIE, 31750 France | ||
Get started
If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here. To order products instantly, request access below.